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Abstract
Curcumin is a natural yellow pigment isolated from the rhizomes of Curcuma longa L. (turmeric), and 
has several pharmacological effects and no toxicity in both in animal and human clinical study. However, 
the problem of curcumin is its stability because of its active methylene moiety. Modifi cation of this moiety to 
cyclopentanone is expected to increase the stability. Previous study reported that benzylidenecyclopentanone 
analogues of curcumin showed inhibitory effect on histamine release from RBL-2H3 (rat basophilic leukemia) 
cells, a tumor analog of mast cells. One of them, the hydroxy-methoxy analog (PGV-0), showed more potent 
effect than that of curcumin. In the present study, some benzylidenecyclopentanone analogues of curcumin were 
evaluated for their effects on the viability and proliferation of RBL-2H3 cells. Viable cells were counted under 
a light microscope with a cells-counting chamber or using the cell viability reagent WST-1. The results showed 
that mast cell viability and histamine content were not affected by curcumin and benzylidene cyclopentanone 
for 30 min incubation, however, impaired for overnight incubation. The hydroxy-dimethyl benzylidene analog 
(PGV-1) strongly decreased the mast cells viability for overnight incubation, and its effect was highest among 
the other analogues. In the proliferation study, this compound also strongly inhibited the proliferation of mast 
cells, whereas curcumin and hydroxy-methoxy benzylidene analog inhibited the proliferation slightly. There 
were no inhibitory effects on mast cells proliferation treated by dibenzylidene; dihydroxybenzylidene; and 
hydroxy-diethylbenzylidene cyclopentanone.
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Introduction
Curcumin, chemically also named as 
1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-
heptadiene-3,5-dione] is a natural yellow 
pigment isolated from the rhizomes of the plant 
Curcuma longa L. (turmeric) widely found in 
south and southeast Asia (Figure 1A). 
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Reportly, curcumin is a potent anticancer in 
various systems. The mechanisms underlying 
this effect are inhibition on transformation, 
tumor initiation, tumor promotion, invasion, 
angiogenesis, and metastasis processes. 
Curcumin has been shown to suppress 
tumorigenic activity of a wide variety of 
carcinogens in cancers of the colon, duodenum, 
esophagus, forestomach, stomach, liver, breast, 
leukaemia, oral cavity, and prostate. 
Besides, curcumin also inhibits the 
proliferation of a wide variety of cancer cell 
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Figure. 1. Structure, chemical name and molecular 
weight of curcumin (A) and its benzylidenecyclopen-
tanone analogues (B)
types in vitro, including cells from cancers of 
the bladder, breast, lung, pancreas, prostate, 
cervix, head and neck, ovary, kidney, and brain; 
and osteosarcoma, leukaemia and melanoma 
(Shishodia et al., 2005; Goel et al., 2008).
Although curcumin has potent anticancer 
effects, its use is limited by the compounds 
instability. Stability of curcumin is strongly 
affected by some aspects such pH and light 
(van der Goot et al., 1995). The kinetics of 
the-pH-dependent degradation of curcumin 
in aqueous medium with various pH was 
studied by Tonnesen and Karlsen (Tonnesen et 
al., 1985). Curcumin in aqueous solution with 
pH less than 7 is quite stable, but at pH more 
than 7 curcumin will be decomposed with 
increasing pH. Modifi cation of the middle 
site of curcumin becomes1,4-pentadiene-3-
ones; cyclopentanone or cyclohexanone still 
maintains the hydroxy moiety responsible 
for antioxidant activities. The compounds 
resulted from these modifi cation are named 
1,5-diphenyl-1,4-pentadiene-3-one analogs, 
benzylidenecyclopentanone, and benzylidene 
hexanone, respectively (Sardjiman et al., 
1997). 
Two benzylidenecyclopentanone 
c u r c u m i n  a n a l o g u e s , 2 , 5 - B i s ( 4 -
methoxybenzylidene) cyclopentanone and 
2,5-Bis(4-hydroxy-3,5-dimethylbenzylidene) 
c y c l o p e n t a n o n e ,  a l s o  n a m e d  a s 
p e n t a g a m a v u n o n - 0  ( P G V - 0 )  a n d 
pentagamavunon-1 (PGV-1) respectively 
(Reksohadiprodjo et al., 2004), were reported 
to possess cytotoxic and antiproliferative 
properties againts T47D human breast cancer 
cell line. These compounds induced apoptosis 
on T47D cell line by increasing p53 and Bax 
expression, and decreasing Bcl-2 expression 
at the protein level. Besides, they have 
been shown that possess antiangiogenesis 
properties by decreasing of VEGF and COX-2 
expressions (Melannisa, 2004; Nurulita and 
Meiyanto, 2006). Moreover, PGV-0 also 
inhibited cell cycle progression through G1 
arrest (Meiyanto and Dai, 2006). Whereas, 
PGV-1 inhibited cell cycle progression through 
G2/M arrest, and induced dephosphorilation 
of CDK-1 on T47d cell line (Dai et al., 2006). 
Investigation of anticarcinogenic 
properties of benzylidenecyclopentanone 
analogues have been studying against other 
kinds of cancer cells. In present study, some 
benzylidenecyclopentanone analogues of 
curcumin including PGV-0 and PGV-1 were 
evaluated for their effects on the viability 
and proliferation of RBL-2H3 (rat basophilic 
leukemia) cells, a tumor analog of mast 
cells.
Materials and Methods
Materials
Curcumin was  purchased f rom 
Sigma-Aldrich (St.  Louis USA), and 
benzylidenecyclopentanone analogues 
of curcumin were kindly supplied by Dr. 
Sardjiman (Faculty of Pharmacy, Universitas 
Gadjah Mada). The chemical structures of 
the compounds are shown in Figure 1B. 
Eagle’s minimum essential medium (MEM) 
and antibiotics (combination of penicillin 
G sodium and streptomycin sulfate) were 
purchased from Gibco (Grand Island, NY, 
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USA). Fetal calf serum was obtained from 
JRH Biosciences (Kansas, USA).  Piperazine-
1,4-bis(2-ethanesulfonic acid) (PIPES) was 
purchased from Dojindo (Kumamoto, 
Japan), and o-phthalaldehyde was from 
Wako Pure Chemical Industries (Osaka, 
Japan). WST reagent used for cytotoxic and 
antiproliferative assays was purchased from 
Roche Diagnostics (Mannheim, Germany).
Assay of cell viability
R B L - 2 H 3  c e l l s  ( D e p a r t m e n t  o f 
Pharmacology, School of Medicine, Ehime 
University Japan) were cultured in MEM 
containing 15% fetal calf serum and antibiotics 
(penicillin and streptomycin) in a fl ask in a 
humidifi ed atmosphere (5% CO2) at 37°C 
as described by Barsumian et al. (1981).The 
fl ask of 25 cm2 containing approximately 1 x 
105 cells/ml were used in the experiments. 
All addition into the medium was sterilized 
by fi ltration in a 0.22-mm millipore fi lter. 
For the assay, cells were seeded into well 
culture plates at a density of 1.25 x 105 
cells/200 ml per each well either without 
(as a negative control) or with the drug. 
The drug concentrations were 1, 10 and 100 
mM. Then, the cells were incubated for 30 
min or 24 h at 37°C. The adherent cells were 
scraped and collected, the cells number were 
counted under a light microscope with a 
cells-counting chamber (Improved Neubauer 
Deep). Besides, cell viability after overnight 
incubation was also assayed directly using 
the cell viability reagent WST-1. 
Assay of cell proliferation
 RBL-2H3 Cells were cultured in 24-well 
plates at the density of 2 x 104 cells/400 ml 
per well in presence or absence of the drugs. 
The cells were incubated in a humidifi ed 
atmosphere of 5% of CO2 at 37°C for certain 
period time. For the study, the cell number 
was determined after 0, 24, 48 and 72 h 
incubation, and using drug concentrations 
at low-toxic concentrations according to 
previous assay, 1 and 3 mM. The number 
of cells was determined under a light 
microscope. After incubation, the RBL-2H3 
cells were washed twice with 500 l of PIPES 
buffer, fi nally added by 500 ml of this buffer. 
The adherent cells were scraped and collected, 
the cells number were counted under a light 
microscope with a cells-counting chamber 
(Improved Neubauer Deep). 
WST assay
In the WST assay, after incubation the 
WST dye solution was added directly into 
the 96-well plate. After 4 h incubation at 37°C, 
the formazan was quantifi ed by absorption 
values detected at 450 nm by microplate 
autoreader. The optical density was measured 
on a microplate reader with a wavelength of 
450 nm. In this assay, the viable cells cleave 
the tetrazolium salts to formazan by cellular 
enzyme, mitochondrial dehydrogenases. 
The augmentation in enzyme activity leads 
to an increase in the amount of formazan 
dye formed, which directly correlates to the 
number of metabolically active cells in the 
sample.
Assay of histamine release
Histamine contents were measured by 
HPLC-fl uorometry as described previously 
study (Yamatodani et al., 1985). After certain 
incubation, the adherent cells were scraped 
and collected. The plate was centrifuged 
at 3,000 rpm for 5 min and 50 ml of the 
supernatant was mixed with 250 ml of 3% 
perchloric acid containing 5mM Na2-EDTA. 
After addition of 30 ml of 2 M KOH/1 M 
KH2PO4 and centrifugation at 10,000 x g for 
15 min at 4°C, 50 ml of the supernatant was 
injected directly onto a column packed with 
TSKgel SP-2SW cation exchanger (Tosoh, 
Tokyo). Histamine was eluted with 0.25 M 
potassium phosphate at a fl ow rate of 0.6 ml/
min, and post-labeled with o-phthalaldehyde 
under alkaline conditions and detected using 
a F1080 Fluorometer (Hitachi, Tokyo) at 
excitation and emission wavelengths of 360 
and 450 nm, respectively.  
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Figure 2. Effects of benzylidenecyclopentanone ana-
logues of curcumin on the density of RBL-2H3 cells (a) 
and the histamine contents (b) during 30 min incuba-
tion. Results are the meanSEM of three experiments. 
The x-axis is logarithmic scale.
Figure 3. Effects of benzylidenecyclopentanone ana-
logues of curcumin on the density of RBL-2H3 cells (a) 
and the histamine contents (b) during 24 h incubation. 
Results are the mean±SEM of three experiments. The 
x-axis is logarithmic scale.
Figure 4. Effects of benzylidenecyclopentanone 
analogues of curcumin on RBL-2H3 cell. Cells were 
incubated for 24 hr with various concentrations of ben-
zylidenecyclopentanone analogues of curcumin. Cell 
proliferations were examined by WST assay. Results 
are the mean?SEM of three experiments. The x-axis is 
logarithmic scale.
Statistical analysis
 All data were expressed as mean ± SEM. 
One-way analysis of variance (ANOVA) 
followed by the least signifi cant difference 
(LSD) test were used for statistical analyses. 
P-values less than 0.05 were considered 
signifi cant.
Results and Discussion
Effects on the viability of RBL-2H3 cells
Figure 2-4 show the effects of a series 
concentration of benzylidenecyclopentanone 
analogues of curcumin on the viability of 
RBL-2H3 (rat basophilic leukemia) cells, a 
tumor analog of mast cells for 30 min and 24 
h incubations. 
Treatment with various concentrations 
of benzylidenecyclopentanone analogues 
of curcumin (1, 10, or 100 μM) for 30 min 
did not influence the viability of RBL-2H3 
cells. However, they markedly decreased the 
viability of RBL-2H3 cells after 24 h incubation 
in dose-dependent manner. It indicates that 
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benzylidenecyclopentanone analogues of 
curcumin caused cytotoxic effects against RBL-
2H3 cells, especially at concentration of 10 and 
100 μM. The cytotoxic effects of most analogues 
are still less potent than this of curcumin. 
However, compound 4 showed more potent 
cytotoxic effect at low concentration (10 μM) 
in compare to this of curcumin.
Effects on the histamine contents in RBL-
2H3 cells
Treatment with a series concentration 
of curcumin (1, 10, or 30 μM) for 30 min 
did not influence histamine contents in 
RBL-2H3 cells. However, they markedly 
decreased the viability of RBL-2H3 cells after 
24 h incubation. The histamine content in 
mast cells was inversely correlated with the 
concentration, indicating its dose-dependent 
inhibitory effect. The decrease in histamine 
contents due to 24 h incubation of the 
compounds are paralleled to the decrease 
in viable mast cells. The effects of most 
analogues on the histamine content were less 
potent than this of curcumin. However, the 
effect of compound  4 was more potent than 
this of curcumin at concentration (10 μM).
Effects on the proliferation of RBL-2H3 
cells
In the study, the cell number was 
determined after 0, 24, 48 and 72 h incubation. 
The drug concentrations used in the study were 
low-toxic concentration according to previous 
assay, 1 and 3 μM. At the concentration 
of 1 μM, only compound 4 attenuated the 
proliferation of RBL-2H3 cells. It obviously 
inhibited the proliferation after 48 h incubation. 
In the other hand, curcumin and all its 
analogues did not infl uence the proliferation 
of the cells. However, at the concentration of 
3 mM curcumin and compound B1 slightly 
attenuated the proliferation of RBL-2H3 cells 
after 72 h incubation. At the same concentration, 
compound 4  showed cytotoxic effect on the 
cells after overnight incubation. The result is 
shown in Table 1.
In  present  s tudy,  benzyl idene-
cyclopentanone curcumin analogues (Figure 
1B) were investigated for their effects on 
viability and proliferation of RBL-2H3 (rat 
basophilic leukemia) cells, a tumor analog 
of mast cells. They did not influence the 
viability of the cells after 30 min incubation, 
however, suppressed the viability after 24 
h incubation. Parallelly, they showed same 
pattern effects on the histamine contents in 
the cells. The effects of most analogues were 
less potent than these of curcumin. However, 
compound 4 showed more potent effects 
than these of curcumin at concentration 
of 10 μM. Previously, this compound also 
showed more potent cytotoxic effect than 
this of curcumin in T47D human breast 
cancer cell line. Moreover, this compound 
Table  1 .  The  e f fec ts  o f  the  t rea tment  o f 
benzylidenecyclopentanone analogues of curcumin at 
doses of 1 μM  (A) and 3 μM (B) on RBL-2H3 cells growth 
during 24, 48, and 72 h
In all plates, 5.0 × 104 cells were seeded per ml. 
The results are presented as mean ± SEM of 3 
experiments.
* Significant difference (P<0.05) compared to the 
negative control value
(A). Dosage 1 μM
Treatment
Number of cell (104 per ml)
24 h 48 h 72 h
Neg. Control 7.02 ± 0.70 23.79 ± 0.72 33.25 ± 0.73
Comp .1 7.02 ± 0.41 24.47 ± 0.72 33.80 ± 0.64
Comp. 2 6.79 ± 0.38 24.69 ± 1.56 31.81 ± 1.42
Comp. 3 6.87 ± 0.61 22.82 ± 0.53 32.84 ± 1.21
Comp. 4 6.56 ± 0.33 8.63 ± 0.85* 5.83 ± 0.97*
Comp. 5 7.02 ± 0.76 23.19 ± 0.65 33.16 ± 0.68
Curcumin 6.95 ± 0.76 23.11 ± 2.31 32.84 ± 0.40
(B). Dosage 3 μM
Treatment
Number of cell (104 per ml)
24 h 48 h 72 h
Neg. Control 7.02 ± 0.70 23.79 ± 0.72 33.25 ± 0.73
Comp .1 7.17 ± 0.59 23.42 ± 0.29 33.79 ± 0.15
Comp. 2 6.92 ± 0.54 22.33 ± 1.70 32.29 ± 0.49
Comp. 3 7.08 ± 0.66 23.25 ± 0.52 28.58 ± 2.33*
Comp. 4 3.04 ± 0.40* 4.29 ± 0.36* 4.25 ± 0.36*
Comp. 5 7.04 ± 0.37 22.79 ± 0.41 31.62 ± 1.61
Curcumin 6.75 ± 0.19 23.12 ± 1.12 28.00 ± 1.45*
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also markedly attenuated the proliferation 
of RBL-2H3 cells at low concentration 
(1 μM), whereas, curcumin and its other 
benzylidenecyclopentanone analogues did 
not infl uence the proliferation at this dose. It 
indicates that compound 4 is prospective to 
be developed as an anti carcinogenic agent.
β-diketon and double bond moieties of 
curcumin have a main role on its anticancer 
and antimutagenic (Majeed et al., 1995). For 
the purpose of curcumin instability, attemp 
to modify the middle site of curcumin 
becomes cyclopentanone resulted in 
benzylidenecyclopentanone analogues 
(Sardjiman et al., 1997). This attemp still 
maintans hydroxy moiety at aromatic 
rings responsible for several biological 
activities, and double bond moiety. Present 
study, compound 3 which has most similar 
structure to curcumin shows possessing 
lower cytotoxicity in RBL-2H3 than this of 
curcumin. Lack of β-diketon is suggested to 
contribute attenuate its cytotoxicity effect. 
Compound 4 is more potent than this of 
compound 3, probably because has four 
methyl moieties, whic are more hydrophobic 
compared to the two methoxy moieties in 
aromatic rings of compound 3. In compound 
5, four ethyl moieties in the aromatic rings 
adjacent to the hydroxyl moieties cause 
hydrophobicity than the four methyl moieties 
in compound 4. However, in the fact the 
potency of compound 5 is less potent than 
this of compound 4. It suggests that the steric 
factor of ethyl is more prominent that its 
hydrophobicity.
Curcumin is reported to possess potent 
anticarcinogenic activities. Curcumin 
suppressed tumorigenic activity of a wide 
variety of carcinogens in cancers in vitro and in 
vivo (Shishodia et al., 2005; Goel et al., 2008). The 
mechanisms of cytotoxic and antiproliferative 
properties of benzylidenecyclopentanone 
curcumin analogues might be similar to these 
of curcumin. Curcumin down-regulated NF-
κB and NF-κB-regulated gene products (IκBα, 
Bcl-2, Bcl-XL, cyclin D1, and interleukin-6) in 
human multiple myeloma leading supression 
of proliferation and arrest of cells at the G1/S 
phase of the cell cycle. The compound induced 
apoptosis of the cells by activating caspase-7 
and -9, and inducing polyadenosine-5’-
diphosphate-ribose polymerase cleavage 
(Bharti et al., 2003). The compound also 
induced apoptosis human renal carcinoma 
Caki cells by down-regulating antiapoptotic 
Bcl-2, Bcl-XL and IAP proteins, stimulating 
release of cytochrome c and activation 
of caspase 3, generating reactive oxygen 
species, and dephosphorilating Akt (Woo 
et al., 2003). Curcumin potently suppressed 
cyclooxigenase-2 enzyme that stimulate 
antiapoptotic Bcl-2 protein (Gafner et al., 
2004).
I n  p r e v i o u s  s t u d i e s ,  t w o 
benzylidenecyclopentanone curcumin 
analogues i.e. compound 3 or 2,5-Bis(4-
methoxybenzylidene)cyclopentanone and 
compound 4 or 2,5-Bis(4-hydroxy-3,5-
dimethylbenzylidene) cyclopentanone 
have been shown to possess cytotoxic and 
antiproliferative properties againts T47D 
human breast cancer cell line. These compound 
are also named as pentagamavunon-0 (PGV-0) 
and pentagamavunon-1 (PGV-1) respectively. 
These compounds induced apoptosis on 
T47D cell line by increasing p53 and Bax 
expression, and decreasing Bcl-2 expression 
at the protein level. They have been shown 
to possess antiangiogenesis properties by 
decreasing of VEGF and COX-2 expressions 
(Melannisa, 2004; Nurulita and Meiyanto, 
2006). Moreover, PGV-0 also inhibited 
cell cycle progression through G1 arrest 
(Meiyanto and Dai, 2006). Whereas, PGV-1 
inhibited cell cycle progression through 
G2/M arrest, and induced dephosphorilation 
of CDK-1 on T47d cell line (Dai et al., 2006). 
We conclude that the curcumin analog 
i.e. compound 4 or 2,5-Bis(4-hydroxy-3,5-
dimethylbenzylidene) cyclopentanone, also 
named as pentagamavunon-1 (PGV-1) has 
been shown to possess more potent cytotoxicity 
and antiproliferative properties than these of 
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other benzylidenecyclopentanone analogues 
of curcumin on RBL-2H3 cell.
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